Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Series A Common Stock, $0.0001 par value per share
-
Shares outstanding
-
31,278,271
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
22,609,183
-
Shares change
-
+8,164,148
-
Total reported value, excl. options
-
$122,544,913
-
Value change
-
+$44,339,223
-
Number of buys
-
66
-
Number of sells
-
16
-
Price
-
$5.42
Institutional Holders of Sagimet Biosciences Inc. - Series A Common Stock, $0.0001 par value per share (SGMT) as of Q1 2024
As of 31 Mar 2024 Sagimet Biosciences Inc. - Series A Common Stock, $0.0001 par value per share (SGMT) had 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 22,609,183 shares of stock of the company.
Largest 10 holders included Point72 Asset Management, L.P., BlackRock Inc., NEA Management Company, LLC, Blue Owl Capital Holdings LP, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, JPMORGAN CHASE & CO, Alyeska Investment Group, L.P., RTW INVESTMENTS, LP, and PFM Health Sciences, LP.
This table shows 81 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.